Correlations Between Symptoms of Anxiety And/or Depression with Dysphagia Severity Level

NCT ID: NCT06587555

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-01

Study Completion Date

2025-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to know any CORRELATIONS BETWEEN SYMPTOMS OF ANXIETY AND / OR DEPRESSION WITH DYSPHAGIA SEVERITY LEVEL in is all of the new or ongoing patients with dysphagia in the Neurorehabilitation Department at Hasan Sadikin General Hospital Bandung and who meet the inclusion and exclusion criteria. The main questions it aims to answer are:

Hypothesis 1 H0 : There is no correlation between increased severity of dysphagia and higher levels of anxiety symptoms H1 : There is a correlation between increased severity of dysphagia and higher levels of anxiety

Hypothesis 2 H0 : There is no correlation between increased severity level of dysphagia and higher level of depression symptoms H1 : There is a correlation between increased severity of dysphagia and higher levels of depression

Hypothesis 3 H0 : There is no correlation between increased severity level of anxiety and dysphagia and higher level of depression symptoms H1 : There is a correlation between increased severity of anxiety and dysphagia and higher levels of depression

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is an analytical observational study with a cross-sectional design, then correlation analysis was carried out, to analyse the correlation between Severity level of dysphagia with anxiety and / or depression. This Study performed at Hasan Sadikin Hospital between August 2024 - March 2025

Study Subject : The target population for this study is all of the new or ongoing patients with dysphagia in the Neurorehabilitation Department at Hasan Sadikin General Hospital Bandung and who meet the inclusion and exclusion criteria.

Inclusion criteria :

* Participants aged 18 years and above.
* Individuals diagnosed with dysphagia by a qualified healthcare professional
* Participants with documented anxiety and/or depression symptoms were assessed using standardized psychological assessments
* Willing to participate

Exclusion criteria :

Participants who have MOCA INA \< 18 Participants with severe malnutrition, showed by BMI WHO Asia Pacific \< 18.5 Participants with unstable hemodynamics, GCS \< 15 Participants who had a history of diagnosed anxiety and / or depression Participants who had a history of using an antipsychotic drug

Sample Size Determination :

The sample size in this study was determined using correlation analysis, to see the correlation between variables, with a minimum number of samples of 30 research subjects obtained.

Confounding Factors :

1. Underlying disease
2. Age
3. Duration of Rehabilitation Therapy
4. Type of Rehabilitation Theraphy

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dysphagia Anxiety Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Participants aged 18 years and above.
2. Individuals diagnosed with dysphagia by a qualified healthcare professional
3. Participants with documented anxiety and/or depression symptoms were assessed using standardized psychological assessments
4. Willing to participate

Exclusion Criteria

1. Participants who have MOCA INA \< 18
2. Participants with severe malnutrition, showed by BMI WHO Asia Pacific \< 18.5
3. Participants with unstable hemodynamics, GCS \< 15
4. Participants who had a history of diagnosed anxiety and / or depression
5. Participants who had a history of using an antipsychotic drug
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitas Padjadjaran

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vitriana Biben

Dr. Vitriana Biben, dr., Sp.K.F.R, NM(K)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vitriana Biben

Role: STUDY_DIRECTOR

University Padjajaran

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hasan Sadikin General Hospital

Bandung, West Java, Indonesia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Indonesia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vitriana Biben

Role: CONTACT

+628156262733

Regina Emmanuela Gusti Pratiwi

Role: CONTACT

+6282119757188

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

vitriana biben, Dr, MD, physiatrist

Role: primary

62 815-6262-733

Regina Emmanuela Gusti Pratiwi, MD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Matsuo K, Palmer JB. Anatomy and physiology of feeding and swallowing: normal and abnormal. Phys Med Rehabil Clin N Am. 2008 Nov;19(4):691-707, vii. doi: 10.1016/j.pmr.2008.06.001.

Reference Type BACKGROUND
PMID: 18940636 (View on PubMed)

Kwon S, Cha S, Kim J, Han K, Paik NJ, Kim WS. Trends in the incidence and prevalence of dysphagia requiring medical attention among adults in South Korea, 2006-2016: A nationwide population study. PLoS One. 2023 Jun 28;18(6):e0287512. doi: 10.1371/journal.pone.0287512. eCollection 2023.

Reference Type BACKGROUND
PMID: 37379287 (View on PubMed)

Kim DY, Park HS, Park SW, Kim JH. The impact of dysphagia on quality of life in stroke patients. Medicine (Baltimore). 2020 Aug 21;99(34):e21795. doi: 10.1097/MD.0000000000021795.

Reference Type BACKGROUND
PMID: 32846813 (View on PubMed)

Bendsen BB, Jensen D, Westmark S, Krarup AL, Riis J, Melgaard D. The Quality of Life in Citizens with Oropharyngeal Dysphagia-A Cross-Sectional Study. J Clin Med. 2022 Jul 20;11(14):4212. doi: 10.3390/jcm11144212.

Reference Type BACKGROUND
PMID: 35887975 (View on PubMed)

Bushuven S, Niebel I, Huber J, Diesener P. Emotional and Psychological Effects of Dysphagia: Validation of the Jugendwerk Dysphagia Emotion and Family Assessment (JDEFA). Dysphagia. 2022 Apr;37(2):375-391. doi: 10.1007/s00455-021-10289-1. Epub 2021 Apr 4.

Reference Type BACKGROUND
PMID: 33817751 (View on PubMed)

Brenes GA. Anxiety, depression, and quality of life in primary care patients. Prim Care Companion J Clin Psychiatry. 2007;9(6):437-43. doi: 10.4088/pcc.v09n0606.

Reference Type BACKGROUND
PMID: 18185823 (View on PubMed)

Verdonschot RJ, Baijens LW, Serroyen JL, Leue C, Kremer B. Symptoms of anxiety and depression assessed with the Hospital Anxiety and Depression Scale in patients with oropharyngeal dysphagia. J Psychosom Res. 2013 Nov;75(5):451-5. doi: 10.1016/j.jpsychores.2013.08.021. Epub 2013 Sep 3.

Reference Type BACKGROUND
PMID: 24182634 (View on PubMed)

Krekeler BN, Broadfoot CK, Johnson S, Connor NP, Rogus-Pulia N. Patient Adherence to Dysphagia Recommendations: A Systematic Review. Dysphagia. 2018 Apr;33(2):173-184. doi: 10.1007/s00455-017-9852-9. Epub 2017 Sep 30.

Reference Type BACKGROUND
PMID: 28965240 (View on PubMed)

Doruk C, Mocchetti V, Rives H, Christos P, Rameau A. Correlations Between Anxiety and/or Depression Diagnoses and Dysphagia Severity. Laryngoscope. 2024 May;134(5):2115-2120. doi: 10.1002/lary.31164. Epub 2023 Nov 9.

Reference Type BACKGROUND
PMID: 37942834 (View on PubMed)

DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000 Jul 24;160(14):2101-7. doi: 10.1001/archinte.160.14.2101.

Reference Type BACKGROUND
PMID: 10904452 (View on PubMed)

Adkins C, Takakura W, Spiegel BMR, Lu M, Vera-Llonch M, Williams J, Almario CV. Prevalence and Characteristics of Dysphagia Based on a Population-Based Survey. Clin Gastroenterol Hepatol. 2020 Aug;18(9):1970-1979.e2. doi: 10.1016/j.cgh.2019.10.029. Epub 2019 Oct 24.

Reference Type BACKGROUND
PMID: 31669055 (View on PubMed)

Karisik A, Dejakum B, Moelgg K, Komarek S, Toell T, Mayer-Suess L, Pechlaner R, Kostner S, Sollereder S, Kiechl S, Rossi S, Schoenherr G, Lang W, Kiechl S, Knoflach M, Boehme C; STROKE-CARD Registry study group. Association between dysphagia and symptoms of depression and anxiety after ischemic stroke. Eur J Neurol. 2024 May;31(5):e16224. doi: 10.1111/ene.16224. Epub 2024 Feb 2.

Reference Type BACKGROUND
PMID: 38308469 (View on PubMed)

Tanaka M, Szabo A, Vecsei L. Integrating Armchair, Bench, and Bedside Research for Behavioral Neurology and Neuropsychiatry: Editorial. Biomedicines. 2022 Nov 22;10(12):2999. doi: 10.3390/biomedicines10122999.

Reference Type BACKGROUND
PMID: 36551755 (View on PubMed)

Mori T, Wakabayashi H, Kishima M, Itoda M, Fujishima I, Kunieda K, Ohno T, Shigematsu T, Oshima F, Ogawa N, Nishioka S, Momosaki R, Shimizu A, Saito Y, Yamada M, Ogawa S. Association between Inflammation and Functional Outcome in Patients with Sarcopenic Dysphagia. J Nutr Health Aging. 2022;26(4):400-406. doi: 10.1007/s12603-022-1769-9.

Reference Type BACKGROUND
PMID: 35450997 (View on PubMed)

Li Y, Hu N, Yang D, Oxenkrug G, Yang Q. Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism. FEBS J. 2017 Mar;284(6):948-966. doi: 10.1111/febs.14026. Epub 2017 Feb 20.

Reference Type BACKGROUND
PMID: 28118532 (View on PubMed)

Nguyen NP, Vos P, Karlsson U, Nguyen P, Dutta S, Lemanski C, Ludin A, Rose S, Nguyen LM, Ward H, Huang S, Sallah S. Quality of life following chemoradiation and postoperative radiation for locally advanced head and neck cancer. ORL J Otorhinolaryngol Relat Spec. 2007;69(5):271-6. doi: 10.1159/000103870. Epub 2007 Jun 12.

Reference Type BACKGROUND
PMID: 17565229 (View on PubMed)

Tiksnadi BB, Triani N, Fihaya FY, Turu' Allo IJ, Iskandar S, Putri DAE. Validation of Hospital Anxiety and Depression Scale in an Indonesian population: a scale adaptation study. Fam Med Community Health. 2023 Jun;11(2):e001775. doi: 10.1136/fmch-2022-001775.

Reference Type BACKGROUND
PMID: 37277187 (View on PubMed)

Soares-Filho GL, Freire RC, Biancha K, Pacheco T, Volschan A, Valenca AM, Nardi AE. Use of the hospital anxiety and depression scale (HADS) in a cardiac emergency room: chest pain unit. Clinics (Sao Paulo). 2009;64(3):209-14. doi: 10.1590/s1807-59322009000300011.

Reference Type BACKGROUND
PMID: 19330247 (View on PubMed)

Dziewas R, Auf dem Brinke M, Birkmann U, Brauer G, Busch K, Cerra F, Damm-Lunau R, Dunkel J, Fellgiebel A, Garms E, Glahn J, Hagen S, Held S, Helfer C, Hiller M, Horn-Schenk C, Kley C, Lange N, Lapa S, Ledl C, Lindner-Pfleghar B, Mertl-Rotzer M, Muller M, Neugebauer H, Ozsucu D, Ohms M, Perniss M, Pfeilschifter W, Plass T, Roth C, Roukens R, Schmidt-Wilcke T, Schumann B, Schwarze J, Schweikert K, Stege H, Theuerkauf D, Thomas RS, Vahle U, Voigt N, Weber H, Werner CJ, Wirth R, Wittich I, Woldag H, Warnecke T. Safety and clinical impact of FEES - results of the FEES-registry. Neurol Res Pract. 2019 Apr 26;1:16. doi: 10.1186/s42466-019-0021-5. eCollection 2019.

Reference Type BACKGROUND
PMID: 33324882 (View on PubMed)

Farooq N, Khatoon S, Malik AN, Rathore FA. Role of Vitalstim(R) In The Management Of Patients With Dysphagia: A MiniReview. J Pak Med Assoc. 2023 Jun;73(6):1346-1348. doi: 10.47391/JPMA.23-46.

Reference Type BACKGROUND
PMID: 37427651 (View on PubMed)

Liang Y, Lin J, Wang H, Li S, Chen F, Chen L, Li L. Evaluating the Efficacy of VitalStim Electrical Stimulation Combined with Swallowing Function Training for Treating Dysphagia following an Acute Stroke. Clinics (Sao Paulo). 2021 Nov 8;76:e3069. doi: 10.6061/clinics/2021/e3069. eCollection 2021.

Reference Type BACKGROUND
PMID: 34755758 (View on PubMed)

Tan Z, Wei X, Tan C, Wang H, Tian S. Effect of neuromuscular electrical stimulation combined with swallowing rehabilitation training on the treatment efficacy and life quality of stroke patients with dysphagia. Am J Transl Res. 2022 Feb 15;14(2):1258-1267. eCollection 2022.

Reference Type BACKGROUND
PMID: 35273727 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IKFR-202408.02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of Fetal Swallowing
NCT00004566 COMPLETED